asa guidelines for glp-1 drugs medications safe to continue before surgery in patients with diabetes and obesity GLP-1 and Anesthesia: Considerations and

Joshua Silva, MD, is a licensed physician and Medical Director of Potere Health MD

The demographic distribution of those most likely to stop treatment was as follows: patients of color, men, people enrolled in Medicare or Medicaid, those living in areas with very high social needs, heart failure, obesity or other cardiovascular diseases prior to drug initiation, and those experiencing new gastrointestinal adverse effects at follow-up [132]

Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents with Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials

GLP-1s could help curb substance abuse including alcohol and opioids, new study finds Increasingly popular GLP-1 drugs used to treat diabetes and obesity show promise in fighting multiple substance use disorders Bookmark GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders and reduce the tragic outcomes they cause, a new study has found

doi: 10.1161/CIRCULATIONAHA.118.036418 42 MarsoS

The present review article strives to assess the safety and benefits of incretin-based therapy, a new class of antidiabetic drug, on the health of patient cardiovascular systems